Joshua C. Doloff

@WJGreenleaf @LuoZhifei You guys already working on gen2 called PIP-skweq?

Our preprint describing the adaptation of the PIP-seq platform for scalable, inexpensive multiomics is now live on BioRxiv! Congrats to Zhifei Luo (@LuoZhifei)! biorxiv.org/content/10.648…

A new Science #Immunology study in mice demonstrates how group B #streptococcus infections in the meninges can trigger dural #macrophage depletion and trigger emergency monocyte production in the skull and peripheral marrow. scim.ag/4aHKtiw

Tilak Ratnanather, associate research professor at #HopkinsBME, has received the 2026 OHBM Diversity and Inclusivity Champion Award for advancing accessibility and inclusion in brain mapping and neuroimaging. Congratulations! 👏 👏 👏 bme.jhu.edu/news-events/ne…

@JHUBME Congrats Tilak!

@MorrisBioEng Congrats Aaron!

It's been a great couple of months for the PRIME lab! We are so excited to start this project and develop new tools to help better understand (and hopefully diagnose and treat!) autoimmunity.

New research by #HopkinsBME engineer @JustusKebschull reveals the brain contains 28 distinct types of dopamine neurons—far more than scientists previously thought. 🧠✨ Read more 👉 bme.jhu.edu/news-events/ne…

Congratulations, Andre! cbsnews.com/baltimore/news…

@humanimmunenews @JHUBME @CellBiomat Thank you for the shoutout!

A new #review from the lab of Dr. Joshua Doloff (@DoloffLab) at @JHUBME highlights how canonically non-immune cells interact with #biomaterials to shape immune responses, and argues for their greater integration into biomaterials research. Read the @CellBiomat review: bit.ly/3SrUIRG

@HopkinsMedicine Congrats Ie-Ming!

We’re proud to celebrate an outstanding achievement: Dr. Ie-Ming Shih, of our Department of Gynecology and Obstetrics, has been selected a recipient of the 2026 Pershing Square Lotus Award for Ovarian Cancer Research — a prestigious recognition of his contributions to advancing women’s health and cancer research.

I've been to 100s of scientific conferences. I've never seen a technical talk get cheers, much less a standing ovation, but this result on pancreatic cancer really deserves it

@HopkinsMedicine @JohnsHopkins @HopkinsEngineer @INBT_JHU @JHUMaterials @HopkinsMedNews @HopkinsMPS

New commentary Immune-competent new approach methodologies for a hybrid future (w/ animal models) just out @NatImmunol! Congrats to co-1st authors @VanceSoares & @victorquiroz68! And co-corresponding authors @MTrapecar & @deokkim1! nature.com/articles/s4159… @JHUBME @TTECJHU

12 #HopkinsBME undergrads have been selected for two of the university’s top summer research fellowships. From PURA projects on pain, imaging, & AI to BDP research in epigenetics & chromatin biology, they’ll spend the summer advancing medical innovation. bme.jhu.edu/news-events/ne…

Many thanks to @CellBiomat Scientific Editor Elaine Jeong for your stewardship as well!

New OpenAccess @CellBiomat review “Immune roles of canonically non-immune cells in biomaterial response” from our teams! sciencedirect.com/science/articl… @JHUBME @TTECJHU @JohnsHopkins @HopkinsEngineer @HopkinsMedicine P.S. - Hope everyone has a safe and meaningful Memorial Day.

However, these findings are often treated as secondary rather than explored in depth. As a result, this emerging area represents a substantial opportunity for both mechanistic discovery and therapeutic innovation.

Evidence of these immune-related functions of canonically non-immune cells appears in the biomaterials literature, most frequently in the contexts of fibrosis, cancer, tolerance, and tissue regeneration.